Federal Register / Vol. 75, No. 68 / Friday, April 9, 2010 / Notices 18165 

the objectives of the Javits-WagnerO’Day Act (41 U.S.C. 46–48c) in 

connection with the products proposed 

for deletion from the Procurement List. 

End of Certification 

The following products are proposed 

for deletion from the Procurement List: 

Products 

Scarf, Branch of Service 

NSN: 8455–00–916–8398 

NPA: UNKNOWN 

Contracting Activity: Defense Supply Center 

Philadelphia, Philadelphia, PA. 

Solvent, Correction Fluid 

NSN: 7510–01–333–6241 

NPA: Lighthouse for the Blind, St. Louis, MO 

Contracting Activity: Federal Acquisition 

Service, GSA/FSS OFC SUP Ctr—Paper 

Products, New York, NY. 

Patricia Briscoe, 

Deputy Director, Business Operations. 

[FR Doc. 2010–8095 Filed 4–8–10; 8:45 am] 

BILLING CODE 6353–01–P 

CONSUMER PRODUCT SAFETY 

COMMISSION 

Notice of Meeting of Chronic Hazard 

Advisory Panel on Phthalates 

AGENCY: Consumer Product Safety 

Commission. 

ACTION: Notice of meeting. 

SUMMARY: The Consumer Product Safety 

Commission (Commission) announces 

the first meeting of the Chronic Hazard 

Advisory Panel (CHAP) on Phthalates. 

The Commission appointed this CHAP 

to study the effects on children’s health 

of all phthalates and phthalate 

alternatives as used in children’s toys 

and child care articles, pursuant to 

section 108 of the Consumer Product 

Safety Improvement Act of 2008 

(CPSIA) (Pub. L. 110–314). 

DATES: The meeting will be held from 9 

a.m. to 5 p.m. on Wednesday, April 14 

and from 9 a.m. to 4 p.m. on Thursday, 

April 15, 2010. 

ADDRESSES: The meeting will be held in 

the fourth floor hearing room in the 

Commission’s offices at 4330 East West 

Highway, Bethesda, Maryland. 

Online Registration: Members of the 

public who wish to attend the meeting 

are requested to preregister online at 

http://www.cpsc.gov/cgibin/chap.aspx. 

This meeting will also be available live 

via Web cast at http://www.cpsc.gov/ 

webcast. Registration is not necessary to 

view the Web cast. 

FOR FURTHER INFORMATION CONTACT: 

Michael Babich, Directorate for Health 

Sciences, Consumer Product Safety 

Commission, Bethesda, MD 20814; 

telephone (301) 504–7253; e-mail 

mbabich@cpsc.gov. 

SUPPLEMENTARY INFORMATION: The 

Commission has previously investigated 

potential risks posed to children from 

phthalate plasticizers, especially di(2- 

ethylhexyl) phthalate (DEHP) and 

diisononyl phthalate (DINP), which 

were used to soften some children’s 

teethers, rattles, and toys made from 

polyvinyl chloride (PVC). Phthalates 

can leach from such products when they 

are mouthed by children, causing some 

phthalates to be ingested. In addition, 

children and adults can be exposed to 

phthalates from many sources, 

including consumer products, food, 

cosmetics, medical devices, and the 

environment. Certain phthalates have 

been shown to cause adverse health 

effects, including birth defects, in 

laboratory animals. 

Section 108 of the CPSIA permanently 

prohibits the sale of any ‘‘children’s toy 

or child care article’’ containing more 

than 0.1 percent of three specified 

phthalates—DEHP, dibutyl phthalate 

(DBP), and benzyl butyl phthalate 

(BBP). Section 108 of the CPSIA also 

prohibits, on an interim basis, the sale 

of ‘‘toys that can be placed in a child’s 

mouth’’ or ‘‘child care articles’’ 

containing more than 0.1 percent of 

three additional phthalates—DINP, 

diisodecyl phthalate (DIDP), and di-noctyl phthalate (DNOP). 

Moreover, section 108 of the CPSIA 

requires the Commission to convene a 

CHAP ‘‘to study the effects on children’s 

health of all phthalates and phthalate 

alternatives as used in children’s toys 

and child care articles.’’ The CPSIA 

requires the CHAP to complete an 

examination of the full range of 

phthalates that are used in products for 

children and to: (i) Examine all of the 

potential health effects (including 

endocrine disrupting effects) of the full 

range of phthalates; (ii) consider the 

potential health effects of each of these 

phthalates both in isolation and in 

combination with other phthalates; (iii) 

examine the likely levels of children’s, 

pregnant women’s, and others’ exposure 

to phthalates, based on a reasonable 

estimation of normal and foreseeable 

use and abuse of such products; (iv) 

consider the cumulative effect of total 

exposure to phthalates, both from 

children’s products and from other 

sources, such as personal care products; 

(v) review all relevant data, including 

the most recent, best-available, peerreviewed, scientific studies of these 

phthalates and phthalate alternatives 

that employ objective data collection 

practices or employ other objective 

methods; (vi) consider the health effects 

of phthalates not only from ingestion 

but also as a result of dermal, hand-tomouth, or other exposure; (vii) consider 

the level at which there is a reasonable 

certainty of no harm to children, 

pregnant women, or other susceptible 

individuals and their offspring, 

considering the best available science, 

and using sufficient safety factors to 

account for uncertainties regarding 

exposure and susceptibility of children, 

pregnant women, and other potentially 

susceptible individuals; and (viii) 

consider possible similar health effects 

of phthalate alternatives used in 

children’s toys and child care articles. 

The CHAP’s examination must be 

conducted de novo, and the statute 

contemplates completion of its 

examination within 18 months of 

appointment of the CHAP. The CHAP 

must review prior work on phthalates 

by the Commission, but the 

Commission’s prior work is not to be 

considered determinative. 

The CHAP must make 

recommendations to the Commission 

regarding any phthalates (or 

combinations of phthalates) in addition 

to those identified in section 108 of the 

CPSIA or phthalate alternatives that the 

panel determines should be declared 

banned hazardous substances. The 

Commission selected the CHAP 

members from scientists nominated by 

the National Academy of Sciences. See 

15 U.S.C. 2077, 2030(b). 

The first meeting of the CHAP on 

Phthalates will be held on April 14 and 

15, 2010, in the fourth floor hearing 

room at the Commission’s offices at 

4330 East West Highway, Bethesda, 

Maryland. The meeting will begin at 9 

a.m. both days and is scheduled to end 

at 5 p.m. on April 14 and 4 p.m. on 

April 15. The meeting is open to the 

public, space permitting, but no 

opportunity for public participation in 

the first meeting is scheduled. There 

will be an opportunity in connection 

with the second meeting of the CHAP 

for presentation of oral and written data 

and views (date to be announced). 

At the first CHAP meeting, the CHAP 

will choose its Chair and Vice Chair and 

the CPSC staff will present information 

on the history of the phthalates project, 

the scope of the CHAP on phthalates, 

including a review of the de novo 

examination called for in section 108 

(b)(2)(B)(i) through (vii) of the CPSIA, 

and the CPSC staff’s toxicity reviews 

and other work on phthalates. During 

the remainder of the meeting, the CHAP 

will consider how it will proceed and 

begin its deliberations. 


srobinson on DSKHWCL6B1PROD with NOTICES
18166 Federal Register / Vol. 75, No. 68 / Friday, April 9, 2010 / Notices 

Dated: April 6, 2010. 

Todd A. Stevenson, 

Secretary, Consumer Product Safety 

Commission. 

[FR Doc. 2010–8144 Filed 4–8–10; 8:45 am] 

BILLING CODE 6355–01–P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Federal Advisory Committee; Board of 

Regents of the Uniformed Services 

University of the Health Sciences 

AGENCY: Uniformed Services University 

of the Health Sciences (USU), DoD. 

ACTION: Quarterly meeting notice. 

SUMMARY: Under the provisions of the 

Federal Advisory Committee Act of 

1972 (5 U.S.C., Appendix, as amended) 

and the Sunshine in the Government 

Act of 1976 (5 U.S.C. 552b, as 

amended), this notice announces a 

meeting of the Board of Regents of the 

Uniformed Services University of the 

Health Sciences (USU) on May 14, 2010. 

DATES: The meeting will be held on 

Friday, May 14, 2010, from: 

9 a.m. to 11:30 a.m. (Open Session). 

11:30 a.m. to 12:30 p.m. (Closed 

Session). 

12:30 p.m. to 3:30 p.m. (Open Session). 

ADDRESSES: The meeting will be held at 

the Everett Alvarez Jr. Board of Regents 

Room (D3001), Uniformed Services 

University of the Health Sciences, 4301 

Jones Bridge Road, Bethesda, Maryland 

20814. 

FOR FURTHER INFORMATION CONTACT: 

Janet S. Taylor, Designated Federal 

Official, 4301 Jones Bridge Road, 

Bethesda, Maryland 20814; telephone 

301–295–3066. 

Ms. Taylor can also provide base 

access procedures. 

SUPPLEMENTARY INFORMATION: 

Purpose of the Meeting 

Meetings of the Board of Regents 

assure that USU operates in the best 

traditions of academia. An outside 

Board is necessary for institutional 

accreditation. 

Agenda 

The actions that will take place 

include the approval of minutes from 

the Board of Regents Meeting held 

February 2, 2010; acceptance of reports 

from working committees; approval of 

faculty appointments and promotions; 

and the awarding of post-baccalaureate 

degrees as follows: Doctor of Medicine, 

Ph.D. in Nursing Science, Master of 

Science in Nursing, and master’s and 

doctoral degrees in the biomedical 

sciences and public health. The Acting 

President, USU; the Vice President, 

USU Office of Research; and the 

President, Henry M. Jackson Foundation 

for the Advancement of Military 

Medicine, will also present reports. 

These actions are necessary for the 

University to pursue its mission, which 

is to provide outstanding health care 

practitioners and scientists to the 

uniformed services. 

Meeting Accessibility 

Pursuant to Federal statute and 

regulations (5 U.S.C. 552b, as amended, 

and 41 CFR 102–3.140 through 102– 

3.165) and the availability of space, 

most of the meeting is open to the 

public. Seating is on a first-come basis. 

The closed portion of this meeting is 

authorized by 5 U.S.C. 552b(c)(6) as the 

subject matter involves personal and 

private observations. 

Written Statements 

Interested persons may submit a 

written statement for consideration by 

the Board of Regents. Individuals 

submitting a written statement must 

submit their statement to the Designated 

Federal Official (see FOR FURTHER

INFORMATION CONTACT). If such statement 

is not received at least 10 calendar days 

prior to the meeting, it may not be 

provided to or considered by the Board 

of Regents until its next open meeting. 

The Designated Federal Official will 

review all timely submissions with the 

Board of Regents Chairman and ensure 

such submissions are provided to Board 

of Regents Members before the meeting. 

After reviewing the written comments, 

submitters may be invited to orally 

present their issues during the May 

2010 meeting or at a future meeting. 

Dated: April 5, 2010. 

Mitchell S. Bryman, 

Alternate OSD Federal Register Liaison 

Officer, Department of Defense. 

[FR Doc. 2010–8052 Filed 4–8–10; 8:45 am] 

BILLING CODE 5001–06–P 

DEPARTMENT OF DEFENSE 

Department of the Army, Corps of 

Engineers 

Notice of Availability of the Draft 

Supplemental Environmental Impact 

Statement for the Proposed Baseload 

Power Plant, East Kentucky Power 

Cooperative, Inc., Clark County, KY 

AGENCY: U.S. Army Corps of Engineers, 

DoD. 

ACTION: Notice of availability. 

SUMMARY: The U.S. Army Corps of 

Engineers (USACE), in accordance with 

42 U.S.C. 4321 to 4370(f), is issuing this 

notice to advise the public that a Draft 

Supplemental Environmental Impact 

Statement (SEIS) has been prepared and 

is available for review and comment. 

DATES: Written comments on the Draft 

SEIS will be accepted for 45 days 

following publication of the 

Environmental Protection Agency’s 

notice of availability for the Draft SEIS 

in the Federal Register. The USACE 

will hold a public hearing at 7 p.m. 

(EDT) on June 8, 2010. 

ADDRESSES: The Draft SEIS can be 

viewed online at: http:// 

www.ekpc.coop/smith-unit1.html. The 

Draft SEIS will also be available for 

viewing at the locations listed in the 

SUPPLEMENTARY INFORMATION section. 

Comments should be submitted to Mr. 

Michael Hasty, Acting Chief, South 

Section, Regulatory Branch, Louisville 

District, P.O. Box 59, Louisville, KY 

40201–0059. The Public Hearing will be 

held at the Clark County Extension 

Service office located at 1400 Fortune 

Drive in Winchester KY 40391. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Michael Hasty, Acting Chief, South 

Section, Regulatory Branch, Louisville 

District, P.O. Box 59, Louisville, KY 

40201–0059. Phone (502) 315–6676, email: michael.d.hasty@usace.army.mil. 

SUPPLEMENTARY INFORMATION: A final 

EIS and Record of Decision was 

prepared by the U.S. Department of 

Energy in 2002/2003 for a proposed 540 

megawatt coal-fired integrated 

gasification combined cycle (IGCC) 

electric generating plant at the same 

location, the Smith Site. That project, 

known as the Kentucky Pioneer IGCC 

Demonstration Project, was never built. 

The Corps has reviewed the EIS 

prepared by DOE and, based on 

similarities between the two projects, 

has determined to adopt that EIS as the 

basis for review of the current proposal. 

The Corps is preparing this 

Supplemental EIS (SEIS) to evaluate 

those aspects of the current proposal 

that are not substantially similar to the 

DOE project, as a result of changes in 

project parameters, existing 

environmental conditions, and relevant 

laws and regulations. 

East Kentucky Power Cooperative, 

Inc. (EKPC) has applied for a 

Department of the Army (DA) permit 

from the U.S. Army Corps of Engineers 

(Corps) to authorize unavoidable 

impacts to jurisdictional waters of the 

U.S. pursuant to Section 404 of the 

Clean Water Act (Section 404) and 

Section 10 of the Rivers and Harbors Act 

(Section 10). 


srobinson on DSKHWCL6B1PROD with NOTICES